Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

IMW 2019 | PROMISE: findings and key considerations

Annie Cowan • 18 Sep 2019
IMW 2019
Multiple Myeloma
PROMISE

Annie Cowan, BA, Dana-Farber Cancer Institute, Boston, MA, discusses the key considerations being made in the uptake of participants in the PROMISE trial (NCT03689595), the importance of screening high-risk individuals for myeloma precursor conditions and some preliminary findings at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Annie Cowan

Insights into the mechanisms leading to progression from MGUS and SMM to multiple myeloma
1:50
Insights into the mechanisms leading to progression from MGUS and SMM to multiple myeloma
Annie Cowan • 26 Aug 2022
An update on the PANGEA model
3:24
An update on the PANGEA model
Annie Cowan • 26 Aug 2022
Recent updates from the PROMISE study
0:50
Recent updates from the PROMISE study
Annie Cowan • 26 Aug 2022
An insight into MGIP and its role in the development of precursor conditions
1:35
An insight into MGIP and its role in the development of precursor conditions
Annie Cowan • 10 Apr 2022

Related Videos

Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
4:32
Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
Annie Cowan • 18 Dec 2025
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
3:36
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
Annie Cowan • 7 Dec 2025
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
3:11
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
Annie Cowan • 7 Dec 2025
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
4:04
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
Annie Cowan • 15 Dec 2025
The content of VJHemOnc is intended for healthcare professionals